154 related articles for article (PubMed ID: 22222426)
1. Late drug eluting stent thrombosis due to acemetacine: type III Kounis syndrome: Kounis syndrome due to acemetacine.
Akyel A; Murat SN; Cay S; Kurtul A; Ocek AH; Cankurt T
Int J Cardiol; 2012 Mar; 155(3):461-2. PubMed ID: 22222426
[No Abstract] [Full Text] [Related]
2. Drug eluting stent-induced Kounis syndrome.
Venturini E; Magni L; Kounis NG
Int J Cardiol; 2011 Jan; 146(1):e16-9. PubMed ID: 19174317
[TBL] [Abstract][Full Text] [Related]
3. Accidentally crushed stent during complex bifurcation treatment. A potential cause of very late stent thrombosis.
Würtz M; Christiansen EH; Kristensen SD; Holm NR
Int J Cardiol; 2015 Oct; 197():113-5. PubMed ID: 26142195
[No Abstract] [Full Text] [Related]
4. Kounis syndrome: a manifestation of drug-eluting stent thrombosis associated with allergic reaction to contrast material.
Kogias JS; Papadakis EX; Tsatiris CG; Hahalis G; Kounis GN; Mazarakis A; Batsolaki M; Gouvelou-Deligianni GV; Kounis NG
Int J Cardiol; 2010 Mar; 139(2):206-9. PubMed ID: 18805597
[TBL] [Abstract][Full Text] [Related]
5. Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy.
Varghese I; Ummer A; Roesle M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2008; 9(3):179-81. PubMed ID: 18606381
[TBL] [Abstract][Full Text] [Related]
6. Amoxicillin-induced Kounis syndrome manifesting as late stent thrombosis.
Venturini E; Magni L; Kounis NG
Int J Cardiol; 2011 Aug; 151(1):e26-8. PubMed ID: 20471121
[No Abstract] [Full Text] [Related]
7. Cardiogenic shock secondary to metamizole-induced type II Kounis syndrome.
Garcipérez de Vargas FJ; Mendoza J; Sánchez-Calderón P; Ortiz C; Porro R; Mogollón-Jiménez MV
Rev Esp Cardiol (Engl Ed); 2012 Dec; 65(12):1138-9. PubMed ID: 22818816
[No Abstract] [Full Text] [Related]
8. Late stent thrombosis or Kounis syndrome?
Horjeti B; Meco S
Int J Cardiol; 2011 Jul; 150(2):e70-2. PubMed ID: 19914724
[TBL] [Abstract][Full Text] [Related]
9. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
[TBL] [Abstract][Full Text] [Related]
10. Kounis syndrome manifesting as coronary aneurysm and very late coronary stent thrombosis.
Hoshi T; Sato A; Akiyama D; Kawabe M; Hiraya D; Aonuma K
JACC Cardiovasc Interv; 2014 Nov; 7(11):e173-6. PubMed ID: 25459048
[No Abstract] [Full Text] [Related]
11. Cefuroxime-axetil induced allergic angina: an insight into classification management of Kounis syndrome.
Murat SN; Karasu BB; Ornek E; Akdemir R
Int J Cardiol; 2011 Sep; 151(2):e53-5. PubMed ID: 20605239
[No Abstract] [Full Text] [Related]
12. Very late drug-eluting stent thrombosis.
Dundon BK; Worthley MI; Worthley SG
Heart Lung Circ; 2008 Apr; 17(2):144-5. PubMed ID: 18365348
[No Abstract] [Full Text] [Related]
13. Simultaneous late stent thrombosis of drug-eluting stents causing acute anterior and inferior myocardial infarction.
Arora N; Aggarwal K
J Invasive Cardiol; 2008 Jan; 20(1):E14-7. PubMed ID: 18174623
[No Abstract] [Full Text] [Related]
14. Acute anterior myocardial infarction due to stent thrombosis after mushroom consumption: A case of Kounis type III syndrome.
Michas G; Stougiannos P; Thomopoulos T; Grigoriou K; Blazakis G; Kaplanis I; Gavrielatos G; Trikas A
Hellenic J Cardiol; 2017; 58(5):378-380. PubMed ID: 28069484
[No Abstract] [Full Text] [Related]
15. Hypersensitivity to drug-eluting stent and stent thrombosis: Kounis or not Kounis syndrome?
Tan W; Cheng KL; Chen QX
Chin Med J (Engl); 2009 Oct; 122(19):2390-3. PubMed ID: 20079145
[No Abstract] [Full Text] [Related]
16. Kounis syndrome is the likely culprit in devastating stent thrombosis.
Kounis NG; Almpanis GC; Tsigkas GG; Mazarakis A
J Invasive Cardiol; 2011 Mar; 23(3):3 p preceding 88. PubMed ID: 21473170
[No Abstract] [Full Text] [Related]
17. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.
Sarno G; Lagerqvist B; Nilsson J; Frobert O; Hambraeus K; Varenhorst C; Jensen UJ; Tödt T; Götberg M; James SK
J Am Coll Cardiol; 2014 Jul; 64(1):16-24. PubMed ID: 24998123
[TBL] [Abstract][Full Text] [Related]
18. Histological confirmation of hypersensitivity as a contributor to very-late coronary stent thrombosis.
Rayoo R; Rayoo M; Ferrante G; Barlis P
Int J Cardiol; 2012 May; 157(2):e29-30. PubMed ID: 21945714
[No Abstract] [Full Text] [Related]
19. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome after angiographically proven coronary stent thrombosis.
Almalla M; Schröder J; Hennings V; Marx N; Hoffmann R
Am J Cardiol; 2013 May; 111(9):1289-94. PubMed ID: 23415513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
